Item 9 Labs Stock Fundamentals
| INLB Stock | USD 0.0001 0.00 0.00% |
Item 9 Labs fundamentals help investors to digest information that contributes to Item 9's financial success or failures. It also enables traders to predict the movement of Item Pink Sheet. The fundamental analysis module provides a way to measure Item 9's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Item 9 pink sheet.
Item |
Item 9 Labs Company Profit Margin Analysis
Item 9's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Item 9 Profit Margin | (1.43) % |
Most of Item 9's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Item 9 Labs is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Item 9 Labs has a Profit Margin of -1.4314%. This is 87.23% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The profit margin for all United States stocks is 12.71% higher than that of the company.
Item 9 Labs Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Item 9's current stock value. Our valuation model uses many indicators to compare Item 9 value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Item 9 competition to find correlations between indicators driving Item 9's intrinsic value. More Info.Item 9 Labs is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Item 9 by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Item 9's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Item Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Item 9's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Item 9 could also be used in its relative valuation, which is a method of valuing Item 9 by comparing valuation metrics of similar companies.Item 9 is currently under evaluation in profit margin category among its peers.
Item Fundamentals
| Return On Equity | -0.42 | |||
| Return On Asset | -0.0721 | |||
| Profit Margin | (1.43) % | |||
| Operating Margin | (0.60) % | |||
| Current Valuation | 52.06 M | |||
| Shares Outstanding | 100 M | |||
| Shares Owned By Insiders | 25.71 % | |||
| Price To Book | 0.28 X | |||
| Price To Sales | 0.95 X | |||
| Revenue | 21.76 M | |||
| Gross Profit | 7.31 M | |||
| EBITDA | (22.83 M) | |||
| Net Income | (31.14 M) | |||
| Cash And Equivalents | 441.66 K | |||
| Total Debt | 7.22 M | |||
| Debt To Equity | 0.39 % | |||
| Current Ratio | 0.14 X | |||
| Book Value Per Share | 0.64 X | |||
| Cash Flow From Operations | (2.25 M) | |||
| Earnings Per Share | (0.18) X | |||
| Target Price | 4.0 | |||
| Number Of Employees | 97 | |||
| Beta | 0.77 | |||
| Market Capitalization | 17.25 M | |||
| Total Asset | 110.76 M | |||
| Z Score | 1.2 | |||
| Net Asset | 110.76 M |
About Item 9 Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Item 9 Labs's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Item 9 using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Item 9 Labs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 103 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Item Pink Sheet
Item 9 financial ratios help investors to determine whether Item Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Item with respect to the benefits of owning Item 9 security.